Statistics
Publications
23
Citations
1.1K
H-Index
16
Active since
2016
Joud Hajjar is an author at Baylor College of Medicine specializing in immunology, life sciences, and cancer immunotherapy.
Publications per year
2016–2023
23
23
Phase 2 study of pembrolizumab in patients with advanced rare cancers
Aung Naing, Funda Meric‐Bernstam, Bettzy Stephen et al. · Journal for ImmunoTherapy of Cancer · 2020 · 131 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +15
Radiomics to predict immunotherapy-induced pneumonitis: proof of concept
Rivka R. Colen, Takeo Fujii, Mehmet Asım Bilen et al. · Investigational New Drugs · 2017 · 120 citations · Full text
Strategies for improving the management of immune-related adverse events
Aung Naing, Joud Hajjar, James L. Gulley et al. · Journal for ImmunoTherapy of Cancer · 2020 · 96 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
1–5 of 23